Significance of lymphoblasts in cerebrospinal fluid in newly diagnosed pediatric acute lymphoblastic malignancies with bone marrow involvement: Possible benefit of dexamethasone

Medical and Pediatric Oncology

Volumn 25, Issue 1, 1995, Pages 22-27

  van den Berg, Henk ^a   Vet, Raymond ^a   den Ouden, Emmy ^a   Behrendt, Henk ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

ALL NHL; children; CSF; lymphoblasts; relapse

Indexed keywords

ASPARAGINASE; DEXAMETHASONE; METHOTREXATE; PREDNISOLONE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW DISEASE; CANCER SURVIVAL; CEREBROSPINAL FLUID; CHILD; DRUG EFFICACY; FOLLOW UP; HUMAN; LYMPHOBLAST; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; STEROID THERAPY;

ADOLESCENT; BONE MARROW; CENTRAL NERVOUS SYSTEM NEOPLASMS; CEREBROSPINAL FLUID; CHILD; CHILD, PRESCHOOL; DATA COLLECTION; DEXAMETHASONE; HUMAN; INFANT; LEUKEMIA, B-CELL, ACUTE; LYMPHOCYTES; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 0029042558     PISSN: 00981532     EISSN: 1096911X     Source Type: Journal    
DOI: 10.1002/mpo.2950250106     Document Type: Article

References (22)

1. Results and significance of six randomized trials in four consecutive ALL‐BFM studies
2. Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy
3. Intensive therapy for children with acute lymphoblastic leukaemia and unfavorable presenting features: Early conclusions of study CCG‐106 by the Childrens Cancer Group
4. High survival rate in advanced‐stage B‐cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: Results from the French Pediatric Oncology Society of a Randomized Trial of 216 Children
5. White matter necrosis, mineralizing microangiopathy, and intellectual abilities in survivors of childhood leukaemia: Associations with central nervous system irradiation and methotrexate therapy
6. Cerebrospinal axis radiation therapy for meningeal leukaemia with dose levels in the range of 2,000 rads
7. The value of maintenance therapy following treatment of central nervous system leukaemia
8. Clinical investigations in the treatment of meningeal leukaemia: Radiation therapy regimens vs. conventional intrathecal methotrexate
9. Neurotoxicity due to central nervous system therapy for childhood leukaemia
10. School performance and psychological adjustment of children treated for leukaemia
11. Low leucocyte counts with blast cells in cerebrospinal fluid in children with newly diagnosed acute lymphoblastic leukaemia
12. On behalf of the SFOP: High survival rate of childhood B‐cell lymphoma and leukaemia (ALL) as result of the LMB 89 protocol of the SFOP
13. Report and recommendations of the Rome workshop concerning poor‐prognosis acute lymphoblastic leukaemia in children: Biologic bases for staging, stratification, and treatment
14. Intraventricular versus intralumbar methotrexate for central‐nervous‐system leukaemia: Prolonged remission with the Ommaya reservoir
15. Blasts in CSF with normal cell count do not justify alteration of therapy for acute lymphoblastic leukemia in remission: A Childrens Cancer Group Study
16. Dexamethasone: its effectiveness in the treatment of the acute symptoms of meningeal leukaemia
17. Lower incidence of meningeal leukaemia when prednisone is replaced by dexamethasone in the treatment of acute lymphoblastic leukaemia
18. Corticosteroid therapy in pediatric practice
19. Differences in cerebrospinal fluid penetration of corticosteroids. Possible relationship to the prevention of meningeal leukaemia
20. Glucocorticoid binding proteins in human leukemic lymphoblasts
21. Glucocorticoid‐binding proteins in human acute lymphoblastic leukemic blast cells
22. The significance of an isolated central nervous system relapse, occurring as first relapse in children with acute lymphoblastic leukemia